Ventyx Biosciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell VTYX and other ETFs, options, and stocks.

About VTYX

Ventyx Biosciences, Inc. engages in developing novel small molecule therapeutics for the treatment of autoimmune diseases. Its clinical stage pipeline includes VTX958, a Phase 1 allosteric TYK2 inhibitor for the treatment of a broad range of autoimmune diseases, VTX002, a Phase 2-ready S1P1 receptor modulator for the treatment of ulcerative colitis, and VTX2735, a Phase 1-ready peripheral inhibitor of the NLRP3 inflammasome, which is a mediator of multiple inflammatory conditions. 

CEO
Raju S. Mohan
CEORaju S. Mohan
Employees
82
Employees82
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2018
Founded2018
Employees
82
Employees82

VTYX Key Statistics

Market cap
85.36M
Market cap85.36M
Price-Earnings ratio
-0.60
Price-Earnings ratio-0.60
Dividend yield
—
Dividend yield—
Average volume
1.06M
Average volume1.06M
High today
$1.35
High today$1.35
Low today
$1.17
Low today$1.17
Open price
$1.27
Open price$1.27
Volume
872.96K
Volume872.96K
52 Week high
$5.66
52 Week high$5.66
52 Week low
$0.783
52 Week low$0.783

Analyst ratings

75%

of 8 ratings
Buy
75%
Hold
25%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.